Vitamin_NN
D_NN
receptor_NN
expression_NN
in_IN
human_JJ
lymphocytes_NNS
._.

Signal_NN
requirements_NNS
and_CC
characterization_NN
by_IN
western_NN
blots_NNS
and_CC
DNA_NN
sequencing_NN
._.

The_DT
signals_NNS
controlling_VBG
the_DT
expression_NN
of_IN
the_DT
receptor_NN
protein_NN
for_IN
1_CD
alpha,25-dihydroxyvitamin_NN
D3_NN
in_IN
normal_JJ
human_JJ
lymphocytes_NNS
and_CC
the_DT
relationship_NN
of_IN
this_DT
protein_NN
to_TO
the_DT
classical_JJ
vitamin_NN
D_NN
receptor_NN
were_VBD
examined_VBN
._.

Lymphocytes_NNS
activated_VBN
with_IN
the_DT
OKT3_NN
antibody_NN
to_TO
the_DT
T-cell_NN
antigen_NN
receptor_NN
expressed_VBD
fewer_JJR
binding_VBG
sites_NNS
as_IN
compared_VBN
to_TO
lymphocytes_NNS
that_WDT
were_VBD
activated_VBN
by_IN
the_DT
polyclonal_JJ
activator_NN
phytohemagglutinin_NN
-LRB-_-LRB-
PHA_NN
-RRB-_-RRB-
._.

However_RB
,_,
combination_NN
of_IN
OKT3_NN
and_CC
phorbol_NN
myristate_NN
acetate_NN
produced_VBD
a_DT
concentration_NN
of_IN
binding_NN
sites_NNS
similar_JJ
to_TO
the_DT
PHA-activated_JJ
cells_NNS
._.

The_DT
receptor_NN
from_IN
OKT3_NN
and_CC
OKT3_NN
+_CC
phorbol_NN
myristate_NN
acetate-activated_JJ
lymphocytes_NNS
exhibited_VBD
decreased_VBN
binding_NN
to_TO
DNA-cellulose_NN
compared_VBN
to_TO
PHA-activated_JJ
lymphocytes_NNS
._.

In_IN
lymphocytes_NNS
activated_VBN
either_CC
by_IN
PHA_NN
or_CC
OKT3_NN
-LRB-_-LRB-
but_CC
not_RB
in_IN
resting_VBG
cells_NNS
-RRB-_-RRB-
,_,
a_DT
50-kDa_JJ
species_NNS
cross-reacting_VBG
with_IN
a_DT
monoclonal_JJ
antibody_NN
against_IN
the_DT
intestinal_JJ
vitamin_NN
D_NN
receptor_NN
was_VBD
detected_VBN
._.

Finally_RB
,_,
RNA_NN
from_IN
activated_VBN
lymphocytes_NNS
was_VBD
amplified_VBN
by_IN
polymerase_NN
chain_NN
reaction_NN
using_VBG
oligonucleotide_NN
primers_NNS
flanking_VBG
the_DT
196_CD
base_NN
pair_NN
long_JJ
region_NN
encoding_VBG
the_DT
DNA-binding_JJ
domain_NN
of_IN
the_DT
human_JJ
intestinal_JJ
receptor_NN
._.

The_DT
amplified_VBN
product_NN
showed_VBD
an_DT
identical_JJ
nucleotide_NN
sequence_NN
to_TO
the_DT
DNA-binding_JJ
domain_NN
of_IN
the_DT
human_JJ
intestinal_JJ
receptor_NN
._.

These_DT
findings_NNS
suggest_VBP
that_IN
expression_NN
of_IN
the_DT
1,25_NN
-_:
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
receptor_NN
in_IN
lymphocytes_NNS
is_VBZ
triggered_VBN
by_IN
distinct_JJ
and_CC
contingent_JJ
signals_NNS
,_,
and_CC
that_IN
the_DT
protein_NN
and_CC
the_DT
mRNA_NN
encoding_VBG
it_PRP
are_VBP
identical_JJ
to_TO
the_DT
classical_JJ
vitamin_NN
D_NN
receptor_NN
._.

